Mesa Laboratories Inc(MLAB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 9 at 4:00 PM ET (Korea 11/10 06:00)
Full metrics table
| Index | RUT | P/E | 151.23 | EPS (ttm) | 0.85 | Insider Own | 4.24% | Shs Outstand | 5.6M | Perf Week | 4.8% |
| Market Cap | 0.72B | Forward P/E | 11.74 | EPS next Y | 6.82% | Insider Trans | -3.02% | Shs Float | 5.4M | Perf Month | 0.24% |
| Enterprise Value | 0.85B | PEG | - | EPS next Q | 2.29 | Inst Own | 97.82% | Short Float | 7.29% | Perf Quarter | 14.92% |
| Income | 0.00B | P/S | 2.86 | EPS this Y | -10.69% | Inst Trans | 6.84% | Short Ratio | 3.04 | Perf Half Y | 24.23% |
| Sales | 0.25B | P/B | 3.79 | EPS next 5Y | - | ROA | 1.12% | Short Interest | 0.39M | Perf YTD | 62.83% |
| Book/sh | 33.73 | P/C | 23.3 | EPS past 3/5Y | 90.85% 13.55% | ROE | 2.66% | 52W High | -11.45% ($144.35) | Perf Year | 68.16% |
| Cash/sh | 5.49 | P/FCF | 13.53 | Sales past 3/5Y | 4.38% 13.22% | ROIC | 1.4% | 52W Low | 83.89% ($69.51) | Perf 3Y | 49.22% |
| Dividend Est. | $0.64 (0.5%) | EV/EBITDA | 18.62 | EPS Y/Y TTM | 842.96% | Gross Margin | 57.35% | Volatility(W/M) | 5.6% 3.86% | Perf 5Y | -59.38% |
| Dividend TTM | 0.64 | EV/Sales | 3.39 | Sales Y/Y TTM | 3.04% | Oper. Margin | 9% | ATR (14) | 5.58 | Perf 10Y | 6.37% |
| Dividend Ex-Date | 2026/11/30 | Quick Ratio | 1.32 | EPS Q/Q | -42.44% | Profit Margin | 1.92% | RSI (14) | 50.75 | Recom | 2 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.79 | Sales Q/Q | 1% | SMA20 | 0.66% ($126.98) | Beta | 1.07 | Target Price | $125 |
| Payout | 53.06% | Debt/Eq | 0.85 | Earnings | 2026/11/9 | SMA50 | -0.35% ($128.27) | Rel Volume | 0.92 | Prev Close | $128.25 |
| Employees | 717 | LT Debt/Eq | 0.81 | EPS/Sales Surpr. | 2.1% -1.2% | SMA200 | 21.33% ($105.35) | Avg Volume(3M) | 0.13M | Price | $127.82 |
| IPO | 1984/2/29 | Option/Short | No/Yes | Trades | 3130 | Volume | 118,037 | Change | -0.34% |
🔬 Mesa Laboratories (MLAB) is a U.S. life sciences tools company that designs and manufactures quality control, sterilization validation solutions, and precision measurement instruments for regulated industries such as pharmaceuticals, healthcare, and medical devices. With a focus on spore-based sterilization validation, calibration and data logging, and consumables, the company has built a stable demand base tailored to regulated environments.
Over the past 1 year, on the higher side
11% below its 1-year high.
Traded about as much as usual. That is 92% of its average volume.
Next earnings report: November 9
That is today. The ex-dividend date is November 30.
MLAB earns at a steady pace
Of every $100 in sales, $9.00 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -10.7% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $1,862. Peers typically go for $2,005. Compared with its own 2-year average, it is 59% cheaper now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -59.4%. The S&P 500 did +61% over the same period.
Tap to view numbers
The dividend is on the small side
Pays 0.50% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 97.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #16 of 32 in the industry
Based on market cap of $715M.
ITRI#14 Itron Inc $4B PER 16.2 
ITRN#15 Ituran Location And Control Ltd $1B PER 16.1 MLAB#16 Mesa Laboratories Inc $715M PER 151.2 
VPG#17 Vishay Precision Group Inc $648M PER - 
USBC#18 USBC Inc $148M PER - 
FAQ
What kind of company is MLAB?
MLAB belongs to the Technology sector and operates in the Scientific & Technical Instruments industry.
What is the market cap of MLAB?
The market cap of MLAB is approximately $715M, ranking 2,849 within its sector.
Does MLAB pay dividends?
MLAB has a dividend yield of approximately 0.50%, with an annual dividend of $0.64.
What is the P/E ratio of MLAB?
MLAB has a P/E ratio of approximately 151.2x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for MLAB?
MLAB has recorded a 52-week high of $144.35 and a low of $69.51.
